Bioventix (LSE:BVXP) Cash Flow for Dividends: £-7.83 Mil (TTM As of Dec. 2025)


LSE:BVXP Bioventix PLC LSE:BVXP
62 GF Score
Price £16.75
GF Value £35.80
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioventix Cash Flow for Dividends?

Bioventix LSE:BVXP 62 Cash Flow for Dividends is £-7.83 Mil as of Dec. 2025. GuruFocus rates LSE:BVXP with a GF Score™ of 62/100 and a GF Value™ of £35.80 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Bioventix's cash flow for dividends for the six months ended in Dec. 2025 was £-4.18 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was £-7.83 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Bioventix's quarterly payment of dividends declined from Dec. 2024 (£-4.54 Mil) to Jun. 2025 (£-3.65 Mil) but then increased from Jun. 2025 (£-3.65 Mil) to Dec. 2025 (£-4.18 Mil).

Bioventix's annual payment of dividends declined from Jun. 2023 (£-8.44 Mil) to Jun. 2024 (£-8.25 Mil) and declined from Jun. 2024 (£-8.25 Mil) to Jun. 2025 (£-8.20 Mil).

Bioventix Cash Flow for Dividends Related Terms

Bioventix Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Bioventix's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioventix Cash Flow for Dividends Chart

Bioventix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.71 -7.92 -8.44 -8.25 -8.20

Bioventix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.70 -3.55 -4.54 -3.65 -4.18
LSE:BVXP
62GF Score
Bioventix PLC LSE:BVXP
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioventix Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-7.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of £-7.83 Mil mean?
Bioventix (LSE:BVXP) has a Cash Flow for Dividends of £-7.83 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bioventix and its competitors.
Is Bioventix's Cash Flow for Dividends too high?
Bioventix's current Cash Flow for Dividends is £-7.83 Mil. Overall, Bioventix has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioventix's Cash Flow for Dividends compare to VRTX and REGN?
Bioventix's Cash Flow for Dividends of £-7.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bioventix and its competitors. Bioventix's current Cash Flow for Dividends is £-7.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioventix stock overvalued right now?
Based on GuruFocus' analysis, Bioventix (LSE:BVXP) is currently considered Significantly Undervalued. The stock's GF Value™ is £35.80, compared to a current price of £16.75 — trading 53.2% below its estimated fair value. The current Cash Flow for Dividends is £-7.83 Mil. Bioventix's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Bioventix (LSE:BVXP), the current Cash Flow for Dividends is £-7.83 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioventix (LSE:BVXP) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventix stock appears to be undervalued. The current stock price of £16.75 is trading 53.2% below its estimated GF Value™ of £35.80. GuruFocus considers Bioventix to be Significantly Undervalued.

Key valuation signals for LSE:BVXP:

  • Cash Flow for Dividends: £-7.83 Mil
  • GF Value™: £35.80 vs. price of £16.75 (53.2% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the LSE:BVXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventix Business Description

Other Exchanges 51B:Germany
Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
62GF Score

Get the complete analysis for LSE:BVXP

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£16.75
Price
£35.80
GF Value